Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol pays $24M for early-stage biotech drugs
Bristol pays $24M for early-stage biotech drugs
Bristol pays $24M for early-stage biotech drugs
Submitted by
admin
on September 22, 2011 - 5:32pm
Source:
Yahoo/AP
News Tags:
Bristol-Myers Squibb
Ambrx
Relaxin
fibroblast activation protein
Headline:
Bristol pays $24M for early-stage biotech drugs
Do Not Allow Advertisers to Use My Personal information
